The Palmer Foundation
Source: Vanguard Nigeria Preliminary trials on the use of chloroquine and hydroxychloroquine as prophylaxis for COVID-19 in Nigeria has recorded some level of success. The study protocol, sponsored by LiveWell Initiative in collaboration with frontline healthcare workers in Nigeria, has undergone hypothesis testing among physicians, researchers, pharmacists, and clinicians with online debates on several professional […]
I would remind WHO that if the consent forms fail to inform patients that the dose of HCQ they may receive is much higher than for any other indication, that WHO may be subject to legal action for injuries incurred in its sham of a clinical trial.
Source: AAPS Online Today the Association of American Physicians & Surgeons filed its motion for a preliminary injunction to compel release to the public of hydroxychloroquine by the Food & Drug Administration (FDA) and the Department of Health & Human Services (HHS), in AAPS v. HHS, No. 1:20-cv-00493-RJJ-SJB (W.D. Mich.). Nearly 100 million doses of hydroxychloroquine (HCQ) were […]
Source: Morocco World News Zemmouri believes 78% of Europe’s coronavirus-related deaths could have been avoided if European states had mirrored Morocco’s hydroxychloroquine strategy. Rabat – Jaouad Zemmouri, a Moroccan scientist and president of the Starklab industrial innovation company in France, believes Morocco’s use of chloroquine and its derivatives proved life-saving for the country’s COVID-19 patients. The […]
Source: BioRxiv The pandemic coronavirus COVID-19 affected global health from the end of 2019 to 2020 and may challenge global health in the future. There have been reports of Chloroquine (CQ) and Hydroxychloroquine (HCQ) used in clinical treatment. In our study, we used CCK-8 stain, flow cytometry and immunofluorescent stain to evaluated the toxicity and […]
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
This represents a 25% relative increase in the likelihood of being discharged from hospital, the study said.
Conclusions: In subjects free of COVID-19, we found a small increase in QTc associated with use of chloroquine, but not hydroxychloroquine. We found no increased mortality associated with use of hydroxychloroquine.
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
The Lancet‘s retracted study was based on non-existent data sets furnished by disgraced non-company Surgisphere.
Source: Spectator Big Pharma laughs all the way to the bank. The Fawlty Towers episode ’Don’t Mention the War’ has been banned by the BBC but a new version of the comedy is playing in Britain’s Covid wards called ‘Don’t Mention the Hydroxychloroquine (HCQ).’ The clowns entertaining the injured in Britain’s battle with the coronavirus are Dr […]
It treats patients in the initial phase, if the patient is medicated at the very beginning of the symptoms, the disease may not reach the acute phase, where the use of respirators is necessary.
“As far as prophylaxis is concerned, more than 4,300 doctors and health works were given HCQ as approved by Indian Council of Medical Research (ICMR) out of which around 45 health persons tested positive and recovered later,”
Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies.
All it took for a safe, generic drug — listed for decades by the World Health Organization (WHO) as one of the drugs that should be immediately and universally available worldwide at all times — to be considered dangerous, was for President Trump to say “I happen to feel good about it.”
Source: France Soir Recovery is the large British multi-arm, phase 3 trial evaluating 6 potential treatments for Covid 19. A trial, including 11,000 patients, conducted under close supervision by two Oxford University professors, Peter Horby and Martin Landray. We add the opportunity to interview Martin Landray on 5th June 2020 in an interview which resulted in a […]
He said the SMS hospital was the first hospital to use Hydroxychloroquine and anti-HIV Drugs Lopinavir and Ritonavir in the first few patients of COVID-19 which delivered good outcomes.
For all these reasons, we suspect, Professor Landray of intentional lies as well as Professor Horby of manipulation of CheckNews because of blatant conflicts of interest.
How can we trust the established authorities or prestigious journals when, in this perilous time, trials of an available, inexpensive, long-established drug appear to be designed to fail, while risking the lives of their subjects through deliberate or negligent drug overdoses?
A Sungai Buloh Hospital clinician also described the controversial antimalarial drug, hydroxychloroquine, as an anchor during the peak of the Covid-19 crisis in Malaysia.
Alex Azar explains that the HCQ EUA revoke, means it is available to anyone with a script Source: FDA letter revolking EUA status On the 15th June, the FDA declared in an almost melodramatic reveal that they were revoking the emergency use authorisation on chloroquine sulfate and hydroxychloroquine sulfate. “This means it could be available […]
The hydroxychloroquine (HCQ) arm of the trials had been stopped after publication of the Lancet Surgisphere study, which claimed that patients who received hydroxychloroquine had 35% higher death rates, but the Lancet study was retracted 13 days after publication, as its data turned out to be fabricated.
It is not affected by the FDA’s decision today, and there is no evidence that the use of hydroxychloroquine as a potential prophylaxis presents a health risk in that setting.
The US Food and Drug Administration on Monday revoked its emergency use authorization for hydroxychloroquine to treat Covid-19, but quickly came under fire from President Donald Trump, who said only US agencies have failed to grasp its benefit in fighting the coronavirus.
“Hydroxychloroquine works,” Dr. Varon said. “I know a number of people think that it doesn’t but we have treated more than 100 patients in the hospital with hydroxychloroquine and the patients have done well.”
The study, which was obviously flawed on its face (I commented well before it was exposed that the groupings made no sense), turned out to be produced by a shell company, with unverified data gathered by non-scientists.
India’s ICMR, its official medical research agency, had written to the WHO, telling WHO that the hydroxychloroquine doses being used in the Solidarity trial were 4 times higher than the doses being used in India.
Of the patients I treated, only 5% needed to be hospitalized. Nobody died.
None of the patients died in the studied period and only 6 have to be admitted in conventional hospitalization area.
Source: MedRxiv Abstract: The new SARS-CoV-2 infection named COVID-19 has severely hit our Health System. At the time of writing this paper no medical therapy is officially recommended or has shown results in improving the outcomes in COVID-19 patients. With the aim of diminishing the impact in Hospital admissions and reducing the number of medical […]
Source: MedRxiv Abstract Background: While several trials are ongoing for treatment of COVID-19, scientific research on chemoprophylaxis is still lacking even though it has potential to delay the pandemic allowing us time to complete research on vaccines. Methods: We have conducted a cohort study amongst Health Care Workers (HCW) exposed to COVID-19 patients, at a […]
Source: Jakarta Globe Researchers from Airlangga University, Government’s Covid-19 Task Force, and State Intelligence Agency (BIN) have claimed to have found combinations of medicine that effectively reduce the number of Sars-Cov-2, the coronavirus that causees Covid-19 disease, in the human body. The researchers have submitted the result to several scientific journals for peer review. “We have been conducting research on […]
Source: Journeyman Pictures Protect against censorship: Please share, download and replatform. Please watch from 38 minutes if you don’t have time for the whole documentary right now. Erin Marie Olszewski is a Nurse-turned-investigative journalist, who has spent the last few months on the frontlines of the coronavirus pandemic, on the inside in two radically different […]
Source: HVMN 13 days after publishing a paper on hydroxychloroquine (a potential drug for coronavirus treatment), The Lancet retracted the study due to faulty data. In the midst of a global pandemic, the study (that have since been retracted) was used as a basis for the guidelines set by the WHO, the CDC, elected officials, […]
Source: India Times New Delhi: Union Minister of State for Chemicals and Fertilizers, Mansukh Mandaviya said that the production of Hydroxychloroquine is more than the requirement in India, hence the government has lifted export restrictions on it. “When the COVID crisis started we had two units making Hydroxychloroquine, now we have 12 and production is more than the requirement. Hence, the […]
Source: The Guardian Questions continue for Surgisphere and CEO Sapan Desai as universities deny knowledge of links to firm behind Lancet’s now-disputed blockbuster study. Dozens of scientific papers co-authored by the chief executive of the US tech company behind the Lancet hydroxychloroquine study scandal are now being audited, including onethat a scientific integrity expert claims contains images […]
Source:Israel National News Two controversial coronavirus studies retracted after authors failed to show data was reliable. “Lancet and the BMJ did not do its due diligence, did not do proper peer review process…. which I think they were possiby bought off, doesn’t matter, but whatever the case is, they published something which is not true, […]
Source: Pan American Health Organisation Importance: Patients in long-term care facilities (LTCF) are at a high-risk of contracting COVID-19 due to advanced age and multiple comorbidities. Without effective treatments, outbreaks in such facilities will become commonplace and will result in severe morbidity and mortality. The effectiveness of doxycycline (DOXY) and hydroxychloroquine (HCQ) combination therapy in […]
Dr. Anthony Fauci has been deliberately blocking a drug which was endorsed by the CDC 15 years ago for treatment of SARS-1 Coronavirus.
The fatality rate among the police personnel in Mumbai due to COVID-19 is just one per cent, thanks to the prophylactic use of HCQ.